• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

R2eD AVM 评分对脑动静脉畸形破裂表现可能性的预测的外部验证。

External Validation of the R2eD AVM Score to Predict the Likelihood of Rupture Presentation of Brain Arteriovenous Malformations.

机构信息

Department of Neurosurgery, Geisinger, Danville, Pennsylvania, USA.

Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.

出版信息

Neurosurgery. 2021 Jul 15;89(2):220-226. doi: 10.1093/neuros/nyab108.

DOI:10.1093/neuros/nyab108
PMID:33957673
Abstract

BACKGROUND

The R2eD AVM scoring system has been recently proposed to predict the risk of hemorrhagic presentation of brain arteriovenous malformations (AVMs).

OBJECTIVE

To perform the first external validation of this R2eD AVM score.

METHODS

Over a retrospective 10-yr period from 2009 to 2019, 122 patients with brain AVMs fit the inclusion criteria. All components required to calculate the R2eD AVM score had to be available. Patient demographics and score calculations were recorded, as well as the circumstances of their presentation. Multivariable analysis was performed to assess predictors of rupture in the study cohort. Next, area under the receiver operating characteristics and linear-by-linear association were employed to assess the effectiveness of the models.

RESULTS

The mean age of the entire cohort was 45.2 yr, and 8% of patients were nonwhite. A total of 48 (39.3%) patients presented with AVM rupture. In univariable analysis, all 5 categories demonstrated P < .15 association with rupture risk. In multivariable analysis, race (nonwhite), size <3 cm, and exclusive deep venous drainage remained in the model with an area under the curve (AUC) of 0.677. The utilization of the R2eD AVM score yielded an AUC of 0.711.

CONCLUSION

Even though mitigated by sample size, this study demonstrated acceptable external validity of the R2eD AVM score.

摘要

背景

最近提出了 R2eD AVM 评分系统,以预测脑动静脉畸形(AVM)出血表现的风险。

目的

对该 R2eD AVM 评分进行首次外部验证。

方法

在 2009 年至 2019 年的 10 年回顾性研究期间,122 名符合脑 AVM 纳入标准的患者。需要计算 R2eD AVM 评分的所有成分都必须可用。记录患者的人口统计学数据和评分计算结果,以及他们的表现情况。进行多变量分析以评估研究队列中破裂的预测因素。接下来,使用受试者工作特征曲线下面积和线性-线性关联来评估模型的有效性。

结果

整个队列的平均年龄为 45.2 岁,8%的患者为非白人。共有 48 名(39.3%)患者出现 AVM 破裂。在单变量分析中,所有 5 个类别均与破裂风险呈 P < 0.15 关联。在多变量分析中,种族(非白人)、大小 <3 cm 和单纯深部静脉引流在模型中仍然存在,曲线下面积(AUC)为 0.677。R2eD AVM 评分的使用产生了 0.711 的 AUC。

结论

尽管受到样本量的限制,但本研究表明 R2eD AVM 评分具有可接受的外部有效性。

相似文献

1
External Validation of the R2eD AVM Score to Predict the Likelihood of Rupture Presentation of Brain Arteriovenous Malformations.R2eD AVM 评分对脑动静脉畸形破裂表现可能性的预测的外部验证。
Neurosurgery. 2021 Jul 15;89(2):220-226. doi: 10.1093/neuros/nyab108.
2
External validation of the R2eD AVM scoring system to assess rupture risk in pediatric AVM patients.R2eD AVM 评分系统评估儿科 AVM 患者破裂风险的外部验证。
J Neurosurg Pediatr. 2023 Feb 24;31(5):469-475. doi: 10.3171/2023.1.PEDS22310. Print 2023 May 1.
3
ReD AVM Score.Red 动静脉畸形评分。
Stroke. 2019 Jul;50(7):1703-1710. doi: 10.1161/STROKEAHA.119.025054. Epub 2019 Jun 6.
4
Commentary: External Validation of the R2eD AVM Score to Predict the Likelihood of Rupture Presentation of Brain Arteriovenous Malformations.评论:R2eD动静脉畸形评分的外部验证,以预测脑动静脉畸形破裂表现的可能性。
Neurosurgery. 2021 Aug 16;89(3):E162-E164. doi: 10.1093/neuros/nyab225.
5
Commentary: External Validation of the R2eD AVM Score to Predict the Likelihood of Rupture Presentation of Brain Arteriovenous Malformations.评论:R2eD AVM评分用于预测脑动静脉畸形破裂表现可能性的外部验证
Neurosurgery. 2021 Jul 15;89(2):E109-E111. doi: 10.1093/neuros/nyab151.
6
External validation of brain arteriovenous malformation haemorrhage scores, AVICH, ICH and R2eD.脑动静脉畸形出血评分(AVICH)、ICH 和 R2eD 的外部验证。
Acta Neurochir (Wien). 2022 Jun;164(6):1685-1692. doi: 10.1007/s00701-022-05190-1. Epub 2022 Apr 18.
7
Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.遗传性出血性毛细血管扩张症患者脑动静脉畸形的患病率和特征:系统评价和荟萃分析。
J Neurosurg. 2017 Aug;127(2):302-310. doi: 10.3171/2016.7.JNS16847. Epub 2016 Oct 21.
8
The Effect of Flow-Related Aneurysms on Hemorrhagic Risk of Intracranial Arteriovenous Malformations.血流相关性动脉瘤对颅内动静脉畸形出血风险的影响。
Neurosurgery. 2019 Oct 1;85(4):466-475. doi: 10.1093/neuros/nyy360.
9
Multicenter assessment of morbidity associated with cerebral arteriovenous malformation hemorrhages.脑动静脉畸形出血相关发病率的多中心评估
J Neurointerv Surg. 2017 Jul;9(7):664-668. doi: 10.1136/neurintsurg-2016-012485. Epub 2016 Jun 22.
10
The Ruptured Arteriovenous Malformation Grading Scale (RAGS): An Extension of the Hunt and Hess Scale to Predict Clinical Outcome for Patients With Ruptured Brain Arteriovenous Malformations.RAGS(破裂动静脉畸形分级量表):Hunt 和 Hess 量表的扩展,用于预测破裂脑动静脉畸形患者的临床转归。
Neurosurgery. 2020 Aug 1;87(2):193-199. doi: 10.1093/neuros/nyz404.

引用本文的文献

1
Development and Validation of a Scoring System for Hemorrhage Risk in Brain Arteriovenous Malformations.脑动静脉畸形出血风险评分系统的建立与验证。
JAMA Netw Open. 2023 Mar 1;6(3):e231070. doi: 10.1001/jamanetworkopen.2023.1070.
2
External validation of brain arteriovenous malformation haemorrhage scores, AVICH, ICH and R2eD.脑动静脉畸形出血评分(AVICH)、ICH 和 R2eD 的外部验证。
Acta Neurochir (Wien). 2022 Jun;164(6):1685-1692. doi: 10.1007/s00701-022-05190-1. Epub 2022 Apr 18.